全球藥物釋放型球囊導管市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計到 2034 年，藥物釋放型球囊導管市場規模將從 2025 年的 12.2 億美元成長至 26.9 億美元，2026 年至 2034 年的複合年成長率為 9.16%。

受心血管疾病盛行率上升和微創手術需求增加的推動，全球藥物釋放型球囊導管市場正經歷穩定成長。這些導管廣泛應用於冠狀動脈和周邊動脈疾病的治療，因為它們能將藥物直接輸送到動脈壁，同時降低血管再阻塞的風險。患者和醫生對先進介入技術的認知不斷提高，也進一步促進了市場擴張。

推動成長要素包括全球人口老化、導致心臟病的不健康生活方式以及導管設計技術的進步。由於藥物釋放型球囊技術相比傳統支架具有恢復時間更短、併發症更少的優勢，因此醫院和專科心臟中心正擴大採用該技術。醫療設備製造商持續不斷的研發活動也促進了產品性能和安全性的提升。

展望未來，新興國家醫療基礎設施的改善以及介入性心臟手術保險覆蓋範圍的擴大預計將對市場產生積極影響。藥物製劑和聯合治療的創新有望進一步改善臨床療效。隨著全球對微創治療的需求持續成長，藥物釋放型球囊導管預計仍將是血管疾病治療的重要解決方案。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球藥物釋放型球囊導管市場：依產品類型分類

• 市場分析、洞察與預測
• 紫杉醇藥物洗脫球囊導管
• Sirolimus藥物洗脫球囊導管

第5章：全球藥物釋放型球囊導管市場：依適應症分類

• 市場分析、洞察與預測
• 冠狀動脈介入治療
• 周邊干預

第6章 全球藥物釋放型球囊導管市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院及門診手術中心
• 導管檢查室
• 其他

第7章 全球藥物釋放型球囊導管市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Meril Life Sciences Pvt. Ltd
  • Medtronic
  • Eurocor Tech GmbH
  • Zhejiang Barty Medical Technology Co. Ltd
  • Biotronik
  • IVascular
  • Lepu Medical Technology（Beijing）Co. Ltd
  • Concept Medical
  • Koninklijke Philips NV

The Drug-eluting Balloon Catheters Market size is expected to reach USD 2.69 Billion in 2034 from USD 1.22 Billion (2025) growing at a CAGR of 9.16% during 2026-2034.

The Global Drug-eluting Balloon Catheters Market is witnessing steady growth due to the rising prevalence of cardiovascular diseases and increasing demand for minimally invasive procedures. These catheters are widely used in treating coronary and peripheral artery diseases, as they deliver medication directly to the arterial wall while reducing the risk of restenosis. Growing awareness among patients and physicians about advanced interventional techniques is further contributing to market expansion.

Key drivers include the aging global population, unhealthy lifestyles leading to heart disorders, and technological advancements in catheter design. Hospitals and specialty cardiac centers are increasingly adopting drug-eluting balloon technologies because they offer shorter recovery times and fewer complications compared to traditional stents. Continuous research and development activities by medical device companies are also enhancing product performance and safety profiles.

Looking ahead, the market is expected to benefit from improved healthcare infrastructure in emerging economies and expanding reimbursement coverage for interventional cardiology procedures. Innovation in drug formulations and combination therapies will likely strengthen clinical outcomes. As demand for minimally invasive treatments continues to rise globally, drug-eluting balloon catheters are projected to remain an important solution in vascular disease management.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Paclitaxel Drug-Eluting Balloon Catheters
• Sirolimus Drug-Eluting Balloon Catheters

By Indication

• Coronary Intervention
• Peripheral Intervention

By End User

• Hospitals and ASCs
• Catheterization Laboratories
• Others

COMPANIES PROFILED

• Becton Dickinson and Company, , Meril Life Sciences Pvt Ltd, Medtronic, Eurocor Tech GmbH, Zhejiang Barty Medical Technology Co Ltd, Biotronik, iVascular, Lepu Medical Technology Beijing Co Ltd, Concept Medical, Koninklijke Philips NV
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DRUG-ELUTING BALLOON CATHETERS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Paclitaxel Drug-Eluting Balloon Catheters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Sirolimus Drug-Eluting Balloon Catheters Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DRUG-ELUTING BALLOON CATHETERS MARKET: BY INDICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Indication
• 5.2. Coronary Intervention Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Peripheral Intervention Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DRUG-ELUTING BALLOON CATHETERS MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals and ASCs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Catheterization Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DRUG-ELUTING BALLOON CATHETERS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Indication
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Indication
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Indication
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Indication
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Indication
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DRUG-ELUTING BALLOON CATHETERS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Meril Life Sciences Pvt. Ltd
  • 9.2.2 Medtronic
  • 9.2.3 Eurocor Tech GmbH
  • 9.2.4 Zhejiang Barty Medical Technology Co. Ltd
  • 9.2.5 Biotronik
  • 9.2.6 IVascular
  • 9.2.7 Lepu Medical Technology (Beijing) Co. Ltd
  • 9.2.8 Concept Medical
  • 9.2.9 Koninklijke Philips N.V